BWCS
BIIB icon

Beirne Wealth Consulting Services’s Biogen BIIB Stock Holding History

Beirne Wealth Consulting Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,471
Closed -$575K – 96
2019
Q3 		$575K Sell
2,471
-28
-1% -$6.52K 0.48% 53
2019
Q2 		$584K Sell
2,499
-541
-18% -$125K 0.52% 54
2019
Q1 		$719K Buy
3,040
+1,842
+154% +$580K 0.56% 50
2018
Q4 		$361K Buy
+1,198
New +$382K 0.31% 105

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Beirne Wealth Consulting Services's BIIB Position: Q4 2019 in Review

Beirne Wealth Consulting Services sold out of Biogen (BIIB) in Q4 2019, closing a stake of 2,471 shares — an estimated $575K sold.

Beirne Wealth Consulting Services first reported a position in BIIB in Q4 2018 and held it in 4 quarters. The position peaked at $719K in Q1 2019. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Beirne Wealth Consulting Services reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Beirne Wealth Consulting Services sold 2,471 Biogen shares in Q4 2019, an estimated $575K.
  • Beirne Wealth Consulting Services first reported a position in Biogen in Q4 2018 and held it in 4 quarters.
  • Beirne Wealth Consulting Services's Biogen position peaked at $719K in Q1 2019.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Beirne Wealth Consulting Services's 13F filing for Q4 2019, filed 14 Jan 2020.